Research Peptide
Tesamorelin 10MG
$70.00
● In Stock
A synthetic 44-amino-acid GHRH analog stabilized against enzymatic degradation, widely studied for visceral adipose tissue, IGF-1 elevation, and cognitive-aging research.
Purity
≥99.4%
Mol. Weight
5,135.9 g/mol
Amino Acid Sequence
44 amino acids (trans-3-hexenoyl-GHRH analog)
Storage
Store lyophilized peptide at -20°C in a sealed vial away from light and moisture. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and use within 30 days. Do not freeze reconstituted solution.
Certificate of Analysis
View third-party lab report · LOT #NP-TESAMO-26
Tesamorelin (TH9507) is a synthetic 44-amino-acid GHRH analog stabilized by a trans-3-hexenoic-acid modification that resists DPP-4 cleavage. It is the only GHRH analog to receive FDA approval, originally for HIV-associated lipodystrophy. Reported research benefits: selective reduction of visceral adipose tissue (~15–18%) without loss of subcutaneous fat; decreased hepatic steatosis in NAFLD/MASLD imaging studies; restoration of the IGF-1 axis in age-related GH decline; improvements in triglycerides, ApoB, and adiponectin; support for lean-mass preservation during caloric restriction; and measurable improvements in executive function and verbal memory in adults with mild cognitive impairment.
Related Products
Retatrutide 30MG
Triple agonist — high-dose vial for extended studies.
Retatrutide 50MG
Triple agonist — bulk presentation for long-term protocols.
Tirzepatide 10MG
First-in-class dual GIP / GLP-1 receptor agonist.